Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-08-07

Clinical Trial Update: Neurobiology of Opioid Dependence: 2 - 2 [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial on neurobiology of opioid dependence sponsored by Yale University has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Yale University | Conditions: Opioid-Related Disorders | Phase 2 | Status: WITHDRAWN